|Anno II – Numero 7 – Marzo 2021|
|Comitato scientifico editoriale: Antonio Magi, Pierluigi Bartoletti, Fernando De Benedetto, Giovanbattista Desideri, Francesco Cognetti, Roberto Messina|
Editore: Intermedia – Direttore Responsabile: Mauro Boldrini – firstname.lastname@example.org
SPECIALE 8 MARZO
Prevenzione e cure su misura per il cuore della donna
8 marzo, Festa della donna. Pensiamo al cuore, non solo come simbolo d’amore, ma come organo che permette di inviare il sangue in tutto l’organismo e nelle donne, che spesso sottovalutano i rischi, si può ammalare.
Gli studi scientifici dicono che per il gentil sesso ci vuole maggior attenzione, sia nella prevenzione attraverso il controllo di specifici fattori di rischio che hanno un maggior peso nelle donne, sia nelle terapie, sia da parte della donna stessa che dai sanitari che la seguono. E soprattutto, se il medico indica cure necessarie per controllare i fattori di rischio, primi tra tutti ipertensione e colesterolo, occorre che la donna segua le prescrizioni, senza “saltare” i trattamenti magari per impegni di famiglia. Insomma, pensiamo al nostro cuore, prima di tutto con una vita sana e poi, sia prima che dopo un eventuale attacco cardiaco, assumendo…
Per continuare a leggere l’intervista alla dottoressa Giovanna Geraci clicca qui
ARTICOLI DALLA LETTERATURA SCIENTIFICA
Adherence to chronic polytherapy in the secondary prevention of myocardial infarction: a matter of gender?
Mirko Di Martino, Michela Alagna, Paolo Francesconi, Francesco Profili, Salvatore Scondotto, Giovanna Fantaci, Gianluca Trifirò, Valentina Isgrò, Marina Davoli, Danilo Fusco
Patients who have had an acute myocardial infarction (AMI) are at increased risk of mortality and morbidity. International guidelines agree on the use of a combination of the following evidence-based (EB) drugs for an effective secondary prevention: antiplatelets, β-blockers, angiotensin-converting-enzyme inhibitors/angiotensin II receptors blockers and statins. The benefits of chronic polytherapy in reducing cardiovascular diseases and mortality have been clearly shown. EB polytherapy for secondary cardiovascular prevention is equally effective in both genders. However, observational studies reported poor adherence in female patients…Read more
New approach to blood pressure control: Triple combination pill
Massimo Volpe, Giovanna Gallo, Giuliano Tocci
Blood pressure (BP) control remains insufficient worldwide, mostly due to poor adherence to treatments, clinical inertia, adverse effects and underuse of drug-combination strategies. Monotherapy and its uptitration have been long considered the first-line strategy in the treatment of hypertension, often leading to ineffective, time consuming and frustrating results. On the other hand, several studies have demonstrated that starting and continuing antihypertensive therapy based on a drug combination is associated with a greater reduction of BP, an earlier achievement of therapeutic goals and a higher proportion of patients achieving targets…Read more
Medication adherence: understanding the issues and finding solutions
Medication is the most frequent treatment intervention, and its success depends on patients taking their medicines in line with their prescribed regimen to yield the full benefit of the treatment. Adherence is especially difficult to ensure in those with multimorbidity, who take multiple medications to manage their conditions. Non-adherence is costly for the health service, both through wastage and increased ill health. Non-adherence may be intentional or non-intentional, and many factors affect an individual’s compliance with a medication regimen. There are a variety of aids that may be helpful; however, the interaction with a health professional…Read more
Impact of Telehealth Interventions on Medication Adherence for Patients With Type 2 Diabetes, Hypertension, and/or Dyslipidemia: A Systematic Review
Jennifer M Bingham, Melissa Black, Elizabeth J Anderson, Yawen Li, Natalie Toselli, Shawna Fox, Jennifer R Martin, David R Axon, Armando Silva-Almodóvar
Objective: To describe telehealth interventions and determine their effect on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia.
Data sources: PubMed/MEDLINE, EMBASE, Cochrane, CINAHL Plus, PsycINFO, Academic Search Ultimate, International Pharmaceutical Abstracts, Scopus, Web of Science, WHO Global Index Medicus, association websites, and gray literature were searched from January 1, 1998, to December 31, 2019…Read more
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction
Suzanne V Arnold, James A de Lemos, Yuyin Liu, Katherine E Mues, Deepak L Bhatt, Christopher P Cannon, Mikhail Kosiborod
This cohort study describes the use of drug therapies to prevent the progression of atherosclerotic cardiovascular disease in US patients with prior myocardial infarction and elevated low-density lipoprotein cholesterol levels.
Conflict of interest statement
Conflict of Interest Disclosures: Dr de Lemos reported receiving personal fees from Amgen, Regeneron, Esperion, and NovoNordisk outside the submitted work…Read more
Medication adherence and predictive factors in patients with cardiovascular disease: A cross-sectional study
Ali Hussein Alek Al-Ganmi, Abdulellah Alotaibi, Leila Gholizadeh, Lin Perry
Adherence to cardiac medications makes a significant contribution to avoidance of morbidity and premature mortality in patients with cardiovascular disease. This quantitative study used cross-sectional survey design to evaluate medication adherence and contributing factors among patients with cardiovascular disease, comparing patients who were admitted to a cardiac ward (n = 89) and those attending outpatient cardiac rehabilitation (n = 31) in Australia. Data collection was completed between October 2016 and December 2017. Descriptive and…Read more
|Questa pubblicazione è resa possibile dal supporto non condizionante di|
|Per iscriversi alla newsletter e contattare la redazione clicca qui |
Per sospendere la ricezione di questa newsletter clicca su Cancellati